Systemic corticosteroids

DRUG5 trials

Conditions

Acute Graft vs Host DiseaseAllergy in ChildrenAnaphylactic ReactionAnaphylaxisIgE Mediated Food AllergyPneumocystisPneumocystis Carinii; Infection, Resulting From HIV DiseasePneumocystis Jiroveci Pneumonia

Phase 1

Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD

CompletedNCT02406651

EVIVE BiotechnologyAcute Graft vs Host Disease

Start: 2016-05-12End: 2020-03-08Updated: 2021-07-22

Phase 4

Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease Recurrence

CompletedNCT01079988

Merck KGaA, Darmstadt, GermanyPsoriasis

Start: 2004-02-29End: 2005-04-30Updated: 2014-02-27

How Long Should we Give Steroids for Patients With Severe PCP

Not yet recruitingNCT07328984

McGill University Health Centre/Research Institute of the McGill University Health CentrePneumocystis, Pneumocystis Carinii; Infection, Resulting From HIV Disease, Pneumocystis Jirovecii Infection +4

Start: 2026-01-30End: 2029-06-30Target: 416Updated: 2026-01-09

Steroid Use in Treatment of Allergic Reactions to Food

RecruitingNCT07341776

Johannes TrueckAllergy in Children, Anaphylactic Reaction, Anaphylaxis +1

Start: 2026-01-26End: 2026-12-01Target: 160Updated: 2026-01-27

Unknown Phase

Characteristics of Ankylosing Spondylitis Associated Uveitis

CompletedNCT07113834

Benha UniversityUveitis

Start: 2023-09-01End: 2024-08-01Updated: 2025-08-11

Related Papers

Dose escalation randomised study of efmarodocokin alfa in healthy volunteers and patients with ulcerative colitis

Gut2023-02-0219 citations

A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract